Evidence map›Paper›PMID 30082317›Full record

ArticleThe Journal of biological chemistry2018

The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.

Fernando Rodríguez-Castañeda, Roza Berhanu Lemma, Ignacio Cuervo, Mads Bengtsen, Lisa Marie Moen, Marit Ledsaak, Ragnhild Eskeland, Odd Stokke Gabrielsen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9.Frontiers in cell and developmental biology · 2023
    Review
  5. Editorial: Role of the SUMOylation in cancer regulation.Frontiers in molecular biosciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Evaluating the Genomic Parameters Governing rAAV-Mediated Homologous Recombination.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fernando Rodríguez-CastañedaFrom the Department of Biosciences, University of Oslo, P. O. Box 1066 Blindern, N-0316 Oslo and.
Roza Berhanu LemmaFrom the Department of Biosciences, University of Oslo, P. O. Box 1066 Blindern, N-0316 Oslo and.
Ignacio CuervoFrom the Department of Biosciences, University of Oslo, P. O. Box 1066 Blindern, N-0316 Oslo and.
Mads BengtsenFrom the Department of Biosciences, University of Oslo, P. O. Box 1066 Blindern, N-0316 Oslo and.
Lisa Marie MoenFrom the Department of Biosciences, University of Oslo, P. O. Box 1066 Blindern, N-0316 Oslo and.
Marit LedsaakFrom the Department of Biosciences, University of Oslo, P. O. Box 1066 Blindern, N-0316 Oslo and.
Ragnhild EskelandFrom the Department of Biosciences, University of Oslo, P. O. Box 1066 Blindern, N-0316 Oslo and.
Odd Stokke GabrielsenFrom the Department of Biosciences, University of Oslo, P. O. Box 1066 Blindern, N-0316 Oslo and o.s.gabrielsen@ibv.uio.no.
University of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The small ubiquitin-like modifier (SUMO) post-translationally modifies lysine residues of transcription factors and co-regulators and thereby contributes to an important layer of control of the activities of these transcriptional regulators. Likewise, deSUMOylation of these factors by the sentrin-specific proteases (SENPs) also plays a role in gene regulation, but whether SENPs functionally interact with other regulatory factors that control gene expression is unclear. In the present work, we focused on SENP1, specifically, on its role in activation of gene expression investigated through analysis of the SENP1 interactome, which revealed that SENP1 physically interacts with the chromatin remodeler chromodomain helicase DNA-binding protein 3 (CHD3). Using several additional methods, including GST pulldown and co-immunoprecipitation assays, we validated and mapped this interaction, and using CRISPR-Cas9-generated CHD3- and SENP1-KO cells (in the haploid HAP1 cell line), we investigated whether these two proteins are functionally linked in regulating chromatin remodeling and gene expression. Genome-wide ATAC-Seq analysis of the CHD3- and SENP1-KO cells revealed a large degree of overlap in differential chromatin openness between these two mutant cell lines. Moreover, motif analysis and comparison with ChIP-Seq profiles in K562 cells pointed to an association of CHD3 and SENP1 with CCCTC-binding factor (CTCF) and SUMOylated chromatin-associated factors. Lastly, genome-wide RNA-Seq also indicated that these two proteins co-regulate the expression of several genes. We propose that the functional link between chromatin remodeling by CHD3 and deSUMOylation by SENP1 uncovered here provides another level of control of gene expression.

Indexed as

Chromatin Assembly and DisassemblyProtein Processing, Post-TranslationalAnimalsCCCTC-Binding FactorCell Line, TumorChlorocebus aethiopsChromatinCloning, MolecularCOS CellsCRISPR-Cas SystemsCysteine EndopeptidasesDNA HelicasesEscherichia coliGene EditingGene ExpressionGenetic VectorsCCCTC-Binding FactorCHD3 protein, humanChromatinCTCF protein, humanCysteine EndopeptidasesDNA HelicasesMi-2 Nucleosome Remodeling and Deacetylase ComplexRecombinant Fusion ProteinsSENP1 protein, humanATAC-seqCHD3chromatin regulationchromatin remodelingHAP1SENP1small ubiquitin-like modifier (SUMO)SUMO proteasesumoylationtranscriptiontranscription coregulator

Identifiers

PMID30082317
PMCPMC6177587
OpenAlexW2887077429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.